Clinical experience with an ethinyl estradiol-desogestrel oral contraceptive. 1989

Y Van Trappen, and P Duvivier, and M Thiery, and H Van Kets, and P Defoort, and W Parewijck, and R Derom, and G Kermans, and P Schoofs
Department of Obstetrics, University Hospital, Gent, Belgium.

Desogestrel (150 micrograms), a potent progestogen virtually devoid of androgenic activity, was used in combination with 30 micrograms ethinyl estradiol as an oral contraceptive preparation (Marvelon). 219 women completed a total of 4074 cycles, and the use-effectiveness was 0.58 Pearl Units. Serious side effects were not observed. The drug-related discontinuation index was 12.8% in six months.

UI MeSH Term Description Entries
D009652 Norpregnenes Pregnenes with one double bond or more than three double bonds which have undergone ring contractions or are lacking carbon-18 or carbon-19..
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D003280 Contraceptives, Oral, Synthetic Oral contraceptives which owe their effectiveness to synthetic preparations.
D004997 Ethinyl Estradiol A semisynthetic alkylated ESTRADIOL with a 17-alpha-ethinyl substitution. It has high estrogenic potency when administered orally, and is often used as the estrogenic component in ORAL CONTRACEPTIVES. 19-Norpregna-1,3,5(10)-trien-20-yne-3,17-diol, (17alpha)-,Ethynyl Estradiol,Estinyl,Ethinyl Estradiol Hemihydrate,Ethinyl Estradiol, (8 alpha)-Isomer,Ethinyl Estradiol, (8 alpha,17 alpha)-Isomer,Ethinyl Estradiol, (8 alpha,9 beta,13 alpha,14 beta)-Isomer,Ethinyl Estradiol, (9 beta,17 alpha)-Isomer,Ethinyl-Oestradiol Effik,Ethinylestradiol Jenapharm,Ethinyloestradiol,Lynoral,Microfollin,Microfollin Forte,Progynon C,Estradiol, Ethinyl,Estradiol, Ethynyl,Ethinyl Oestradiol Effik,Hemihydrate, Ethinyl Estradiol,Jenapharm, Ethinylestradiol
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D013375 Substance Withdrawal Syndrome Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug. Drug Withdrawal Symptoms,Withdrawal Symptoms,Drug Withdrawal Symptom,Substance Withdrawal Syndromes,Symptom, Drug Withdrawal,Symptom, Withdrawal,Symptoms, Drug Withdrawal,Symptoms, Withdrawal,Syndrome, Substance Withdrawal,Syndromes, Substance Withdrawal,Withdrawal Symptom,Withdrawal Symptom, Drug,Withdrawal Symptoms, Drug,Withdrawal Syndrome, Substance,Withdrawal Syndromes, Substance
D017135 Desogestrel A synthetic progestational hormone used often as the progestogenic component of combined oral contraceptive agents (ORAL CONTRACEPTIVES, COMBINED). 18,19-Dinorpregn-4-en-20-yn-17-ol, 13-ethyl-11-methylene-, (17alpha)-,13-Ethyl-11-methylene-18,19-dinor-17 alpha-pregn-4-en-20-yn-17-ol,Cerazette,Marvelon,Org-2969,13 Ethyl 11 methylene 18,19 dinor 17 alpha pregn 4 en 20 yn 17 ol,Org 2969,Org2969,alpha-pregn-4-en-20-yn-17-ol, 13-Ethyl-11-methylene-18,19-dinor-17

Related Publications

Y Van Trappen, and P Duvivier, and M Thiery, and H Van Kets, and P Defoort, and W Parewijck, and R Derom, and G Kermans, and P Schoofs
January 1982, Clinical therapeutics,
Y Van Trappen, and P Duvivier, and M Thiery, and H Van Kets, and P Defoort, and W Parewijck, and R Derom, and G Kermans, and P Schoofs
September 1994, Contraception,
Y Van Trappen, and P Duvivier, and M Thiery, and H Van Kets, and P Defoort, and W Parewijck, and R Derom, and G Kermans, and P Schoofs
January 1992, International journal of fertility,
Y Van Trappen, and P Duvivier, and M Thiery, and H Van Kets, and P Defoort, and W Parewijck, and R Derom, and G Kermans, and P Schoofs
January 1993, International journal of fertility and menopausal studies,
Y Van Trappen, and P Duvivier, and M Thiery, and H Van Kets, and P Defoort, and W Parewijck, and R Derom, and G Kermans, and P Schoofs
March 1975, Fertility and sterility,
Y Van Trappen, and P Duvivier, and M Thiery, and H Van Kets, and P Defoort, and W Parewijck, and R Derom, and G Kermans, and P Schoofs
April 1994, Fertility and sterility,
Y Van Trappen, and P Duvivier, and M Thiery, and H Van Kets, and P Defoort, and W Parewijck, and R Derom, and G Kermans, and P Schoofs
January 1988, Acta obstetricia et gynecologica Scandinavica,
Y Van Trappen, and P Duvivier, and M Thiery, and H Van Kets, and P Defoort, and W Parewijck, and R Derom, and G Kermans, and P Schoofs
March 1993, American journal of obstetrics and gynecology,
Y Van Trappen, and P Duvivier, and M Thiery, and H Van Kets, and P Defoort, and W Parewijck, and R Derom, and G Kermans, and P Schoofs
January 1997, Acta obstetricia et gynecologica Scandinavica. Supplement,
Y Van Trappen, and P Duvivier, and M Thiery, and H Van Kets, and P Defoort, and W Parewijck, and R Derom, and G Kermans, and P Schoofs
September 1989, International journal of fertility,
Copied contents to your clipboard!